Precigen PGEN
NASDAQ PGEN
$7.11 -0.03 (-0.49%)
As of: Sep 4, 2026 · 3:59 PM EDT

Precigen (PGEN) Non-Current Deffered Revenue (2012 - 2025)

Precigen (PGEN) posted quarterly Non-Current Deffered Revenue of $95000.0 for Q3 2025, down 95.32% year-over-year from $2.0 million in Q3 2024, and down 94.77% quarter-over-quarter from $1.8 million in Q2 2025.

Analysis

Precigen (PGEN) Non-Current Deffered Revenue (2012 - 2025) Analysis & Trends

Precigen (PGEN) has reported Non-Current Deffered Revenue for 14 consecutive years, with $95000.0 the latest figure, recorded in Q3 2025.

  • In Q3 2025, Non-Current Deffered Revenue fell 95.32% year-over-year to $95000.0; the TTM figure through Sep 2025 stood at $95000.0 (down 95.32% YoY), while the FY2024 annual figure was $1.9 million, up 6.38% from the prior year.
  • Non-Current Deffered Revenue fell to $95000.0 in Q3 2025 per PGEN's latest filing, from $1.8 million in the prior quarter.
  • Across five years, Non-Current Deffered Revenue topped out at $23.0 million in Q1 2021 and bottomed at $95000.0 in Q3 2025.
  • Historically, Non-Current Deffered Revenue has averaged $8.4 million across 5 years, with a median of $1.8 million in 2025.
  • Annual changes were most pronounced in 2024 — Non-Current Deffered Revenue gained 11.77% — and 2025, when it slumped 95.32%.
  • Precigen's Non-Current Deffered Revenue stood at $23.0 million in 2021, then plunged by 92.1% to $1.8 million in 2022, then changed by 0.0% to $1.8 million in 2023, then increased by 6.38% to $1.9 million in 2024, then slumped by 95.09% to $95000.0 in 2025.
  • Business Quant data shows PGEN's Non-Current Deffered Revenue at $95000.0 in Q3 2025, $1.8 million in Q2 2025, and $1.8 million in Q1 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 220.40 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 147.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -
10 Precigen 2.53 Bn 2.53 Bn 52.17 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 95,000.00
Jun 30, 2025 1.82 Mn
Mar 31, 2025 1.84 Mn
Dec 31, 2024 1.93 Mn
Sep 30, 2024 2.03 Mn
Jun 30, 2024 1.82 Mn
Mar 31, 2024 1.89 Mn
Dec 31, 2023 1.82 Mn
Sep 30, 2023 1.82 Mn
Jun 30, 2023 1.82 Mn
Mar 31, 2023 1.82 Mn
Dec 31, 2022 1.82 Mn
Sep 30, 2022 1.82 Mn
Jun 30, 2022 23.02 Mn
Mar 31, 2022 23.02 Mn
Dec 31, 2021 23.02 Mn
Sep 30, 2021 23.02 Mn
Jun 30, 2021 23.02 Mn
Mar 31, 2021 23.02 Mn
Dec 31, 2020 23.02 Mn